| Fluconazole |
16007/23.02.2007 г. |
EXOMAX, Solution for infusion, 2 mg/ml - 200 ml, mg, Pack: 1 |
Claris Lifesciences (UK) Ltd, Обединено Кралство |
Екофарм ЕООД |
33.95 |
6.79 |
40.74 |
4% |
1.36 |
35.31 |
7.06 |
42.37 |
16% |
5.43 |
40.74 |
8.15 |
48.89 |
|
НСР-8564/24.03.2016. |
08.04.2016 |
08.04.2016 |
Активен |
387 |
| Fluconazole |
16007/23.02.2007 г. |
EXOMAX, Solution for infusion, 2 mg/ml - 100 ml, mg, Pack: 1 |
Claris Lifesciences (UK) Ltd, Обединено Кралство |
Екофарм ЕООД |
16.98 |
3.4 |
20.38 |
6% |
1.02 |
18 |
3.6 |
21.6 |
18% |
3.06 |
21.06 |
4.21 |
25.27 |
|
НСР-8563/24.03.2016. |
08.04.2016 |
08.04.2016 |
Активен |
386 |
| Fluconazole |
16007/23.02.2007 г. |
EXOMAX, Solution for infusion, 2 mg/ml - 200 ml, mg, Pack: 1 |
Claris Lifesciences (UK) Ltd, Обединено Кралство |
Екофарм ЕООД |
61.39 |
12.28 |
73.67 |
4% |
2.46 |
63.85 |
12.77 |
76.62 |
16% |
9.82 |
73.67 |
14.73 |
88.4 |
промяна в обстоятелствата КЦPP-2270/11.02.2013 |
КЦ-390/07.01.2009 |
04.02.2009 |
04.02.2009 |
Неактивен |
387 |
| Fluconazole |
16007/23.02.2007 г. |
EXOMAX, Solution for infusion, 2 mg/ml - 100 ml, mg, Pack: 1 |
Claris Lifesciences (UK) Ltd, Обединено Кралство |
Екофарм ЕООД |
32.41 |
6.48 |
38.89 |
4% |
1.3 |
33.71 |
6.74 |
40.45 |
16% |
5.19 |
38.9 |
7.78 |
46.68 |
промяна в обстоятелствата КЦPP-2270/11.02.2013 |
КЦ-390/07.01.2009 |
04.02.2009 |
04.02.2009 |
Неактивен |
386 |
| Aripiprazole |
20150245 |
Explemed, Tablet, 15, mg, Pack: 28 |
EGIS Pharmaceuticals PLC, Унгария |
EGIS Pharmaceuticals PLCH-1165 Budapest, Bökényföldiút 118-120.Унгария |
84.75 |
16.95 |
101.7 |
4% |
3.39 |
88.14 |
17.63 |
105.77 |
16% |
13.56 |
101.7 |
20.34 |
122.04 |
|
НСР-7029/25.08.2015 |
09.09.2015 |
09.09.2015 |
Активен |
4067 |
| Aripiprazole |
20150226 |
Explemed Rapid, Orodispersible tablet, 15, mg, Pack: 28 |
EGIS Pharmaceuticals PLC, Унгария |
EGIS Pharmaceuticals PLC, H-1165 Budapest, Bökényföldi út 118-120, Унгария |
84.75 |
16.95 |
101.7 |
4% |
3.39 |
88.14 |
17.63 |
105.77 |
16% |
13.56 |
101.7 |
20.34 |
122.04 |
|
НСР-7031/25.08.2015 |
09.09.2015 |
09.09.2015 |
Активен |
4066 |
| Interferon beta-1b |
ЕU/1/08/454/002 |
Extavia, Powder and solvent for solution for injection, 9.6, MIU, Pack: 15 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH, Germany |
981.81 |
196.36 |
1178.17 |
4% |
10 |
991.81 |
198.36 |
1190.17 |
16% |
25 |
1016.81 |
203.36 |
1220.17 |
|
НСР-7473/12.11.2015 |
27.11.2015 |
27.11.2015 |
Активен |
3155 |
| Interferon beta-1b |
ЕU/1/08/454/002 |
Extavia, Powder and solvent for solution for injection, 9.6, MIU, Pack: 15 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH, Germany |
1027.26 |
205.45 |
1232.71 |
4% |
10 |
1037.26 |
207.45 |
1244.71 |
16% |
25 |
1062.26 |
212.45 |
1274.71 |
|
НСР-4537/22.08.2014 |
08.09.2014 |
08.09.2014 |
Неактивен |
3155 |
| Interferon beta-1b |
ЕU/1/08/454/002 |
Extavia, Powder and solvent for solution for injection, 9.6, MIU, Pack: 15 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH, Germany |
1257.27 |
251.45 |
1508.72 |
4% |
10 |
1267.27 |
253.45 |
1520.72 |
16% |
25 |
1292.27 |
258.45 |
1550.72 |
промяна на обстоятелства НСР-4521/22.08.2014 ( в сила от 08.09.2014) |
НСР-1733/21.11.2013 |
09.12.2013 |
09.12.2013 |
Неактивен |
3155 |
| Interferon beta-1b |
ЕU/1/08/454/002 |
Extavia, Powder and solvent for solution for injection, 9.6, MIU, Pack: 15 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharmaceuticals UK Limited, Обединеното кралство |
1259.53 |
251.91 |
1511.44 |
4% |
10 |
1269.53 |
253.91 |
1523.44 |
16% |
25 |
1294.53 |
258.91 |
1553.44 |
|
КЦРР-2188/06.02.2013 г |
25.02.2013 |
25.02.2013 |
Неактивен |
3155 |
| Interferon beta-1b |
ЕU/1/08/454/002 |
Extavia, Powder and solvent for solution for injection, 9.6, MIU, Pack: 15 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharmaceuticals UK Limited, Обединеното кралство |
1737.21 |
347.44 |
2084.65 |
4% |
10 |
1747.21 |
349.44 |
2096.65 |
16% |
25 |
1772.21 |
354.44 |
2126.65 |
|
КЦ-259/20.10.2008 |
08.11.2008 |
08.11.2008 |
Неактивен |
3155 |
| Isotonic Solutions |
II-9718/31.05.2010 |
EXTRANEAL, Solution for peritoneal dialysis, Icodextrin 75 g/l; Sodium chloride 5.4 g/l; Calcium chloride 0.257 g/l, Magnesium chloride 0.051 g/l; Sodium lactate solution 4.5 g/l - 2000 ml, g, Pack: 1 |
Бакстер България ЕООД, България |
Baxter Healthcare S.A. Moneen Road, Castlebar, County Mayo, Ирландия; Baxter Healthcare Ltd., Caxton Way, Thetford, Norfolk IP24 3SE, UK |
13.46 |
2.69 |
16.15 |
6% |
0.81 |
14.27 |
2.85 |
17.12 |
18% |
2.42 |
16.69 |
3.34 |
20.03 |
промяна в обстоятелства НСР-5173/27.11.2014 |
КЦ-1706/09.09.2010 |
24.09.2010 |
24.09.2010 |
Активен |
957 |
| Dasabuvir |
EU/1/14/983/001 |
Exviera, Film coated tablet, 250, mg, Pack: 56 |
AbbVie Ltd, Обединено Кралство |
AbbVie Deutschland GmbH & Co. KG, Knollstrasse 67061 Ludwigshafen, Германия |
2039.23 |
407.85 |
2447.08 |
4% |
10 |
2049.23 |
409.85 |
2459.08 |
16% |
25 |
2074.23 |
414.85 |
2489.08 |
|
НСР-7450/10.11.2015. (допуска се предварително изпълнение); НСР-9629/23.06.2016 |
02.08.2016 |
02.08.2016 |
Активен |
4092 |
| Dasabuvir |
EU/1/14/983/001 |
Exviera, Film coated tablet, 250, mg, Pack: 56 |
AbbVie Ltd, Обединено Кралство |
AbbVie Deutschland GmbH & Co. KG, Knollstrasse 67061 Ludwigshafen, Германия |
2188.12 |
437.62 |
2625.74 |
4% |
10 |
2198.12 |
439.62 |
2637.74 |
16% |
25 |
2223.12 |
444.62 |
2667.74 |
|
НСР-7450/10.11.2015. (допуска се предварително изпълнение) |
10.11.2015 |
10.11.2015 |
Неактивен |
4092 |
| Aflibercept |
EU/1/12/797/002 |
Eylea, Solution for injection, 40 mg/ml - 100µl, mg, Pack: 1 vial |
Bayer Pharma AG, Германия |
Bayer Pharma AG, Müllerstraße 178, D-13353 Berlin, Германия |
1250.75 |
250.15 |
1500.9 |
4% |
10 |
1260.75 |
252.15 |
1512.9 |
16% |
25 |
1285.75 |
257.15 |
1542.9 |
промяна на обстоятелства НСР-9687/30.06.2016 |
НСР-7570/26.11.2015. |
12.12.2015 |
12.12.2015 |
Активен |
4126 |
| Aflibercept |
EU/1/12/797/002 |
Eylea, Solution for injection, 40 mg/ml - 100µl, mg, Pack: 1 vial |
Bayer Pharma AG, Германия |
Bayer Pharma AG, Müllerstraße 178, D-13353 Berlin, Германия; GP Grenzach Produktions GmbH, Emil -Barell-Straße 7, D-79639 Grenzach-Wyhlen, Германия |
1250.75 |
250.15 |
1500.9 |
4% |
10 |
1260.75 |
252.15 |
1512.9 |
16% |
25 |
1285.75 |
257.15 |
1542.9 |
|
НСР-7570/26.11.2015. |
12.12.2015 |
12.12.2015 |
Неактивен |
4126 |
| Agalsidase beta |
EU/1/01/188/001 |
Fabrazyme, Powder for concentrate for solution for infusion, 35, mg, Pack: 1 |
Genzyme Europe B.V., Нидерландия |
Genzyme Ltd., 37 Hollands Road, Haverhill Suffolk CB9 8PU, Великобритания; Genzyme Ireland Ltd., IDA Industrial Park, Old Kilmeaden Road, Waterford, Ирландия |
5170.94 |
1034.19 |
6205.13 |
4% |
10 |
5180.94 |
1036.19 |
6217.13 |
16% |
25 |
5205.94 |
1041.19 |
6247.13 |
промяна в обстоятелства НСР-8697/06.04.2016; корекционно решение НСР-9730/07.07.2016 |
НСР-4745/02.10.2014; НСР-9480/09.06.2016 |
02.07.2016 |
02.07.2016 |
Активен |
3215 |
| Agalsidase beta |
EU/1/01/188/001 |
Fabrazyme, Powder for concentrate for solution for infusion, 35, mg, Pack: 1 |
Genzyme Europe B.V., Нидерландия |
Genzyme Ltd., 37 Hollands Road, Haverhill Suffolk CB9 8PU, Великобритания; Genzyme Ireland Ltd., IDA Industrial Park, Old Kilmeaden Road, Waterford, Ирландия |
5170.94 |
1034.19 |
6205.13 |
4% |
10 |
5180.94 |
1036.19 |
6217.13 |
16% |
25 |
5205.94 |
1041.19 |
6247.13 |
промяна в обстоятелства НСР-8697/06.04.2016. |
НСР-4745/02.10.2014; НСР-9480/09.06.2016 |
02.07.2016 |
02.07.2016 |
Неактивен |
3215 |
| Agalsidase beta |
EU/1/01/188/001 |
Fabrazyme, Powder for concentrate for solution for infusion, 35, mg, Pack: 1 |
Genzyme Europe B.V., Нидерландия |
Genzyme Ltd., 37 Hollands Road, Haverhill Suffolk CB9 8PU, Великобритания; Genzyme Ireland Ltd., IDA Industrial Park, Old Kilmeaden Road, Waterford, Ирландия |
5205.48 |
1041.1 |
6246.58 |
4% |
10 |
5215.48 |
1043.1 |
6258.58 |
16% |
25 |
5240.48 |
1048.1 |
6288.58 |
промяна в обстоятелства НСР-8697/06.04.2016. |
НСР-4745/02.10.2014 |
16.10.2014 |
16.10.2014 |
Неактивен |
3215 |
| Agalsidase beta |
EU/1/01/188/001 |
Fabrazyme, Powder for concentrate for solution for infusion, 35, mg, Pack: 1 |
Genzyme Europe B.V., Нидерландия |
Genzyme Ltd., United Kingdom |
5432.26 |
1086.45 |
6518.71 |
4% |
10 |
5442.26 |
1088.45 |
6530.71 |
16% |
25 |
5467.26 |
1093.45 |
6560.71 |
|
НСР-2288/13.01.2014 |
21.02.2014 |
21.02.2014 |
Неактивен |
3215 |
| Agalsidase beta |
EU/1/01/188/001 |
Fabrazyme, Powder for concentrate for solution for infusion, 35, mg, Pack: 1 |
Genzyme Europe B.V., Нидерландия |
Genzyme Ltd., United Kingdom |
5811.92 |
1162.38 |
6974.3 |
4% |
10 |
5821.92 |
1164.38 |
6986.3 |
16% |
25 |
5846.92 |
1169.38 |
7016.3 |
|
КЦРР-2773/20.03.2013 |
19.04.2013 |
19.04.2013 |
Неактивен |
3215 |
| Agalsidase beta |
EU/1/01/188/001 |
Fabrazyme, Powder for concentrate for solution for infusion, 35, mg, Pack: 1 |
Genzyme Europe B.V., Нидерландия |
Genzyme Ltd., United Kingdom |
5861.64 |
1172.33 |
7033.97 |
4% |
10 |
5871.64 |
1174.33 |
7045.97 |
16% |
25 |
5896.64 |
1179.33 |
7075.97 |
|
КЦРР-756/07.06.2012 |
31.07.2012 |
31.07.2012 |
Неактивен |
3215 |
| Agalsidase beta |
EU/1/01/188/001 |
Fabrazyme, Powder for concentrate for solution for infusion, 35, mg, Pack: 1 |
Genzyme Europe B.V., Нидерландия |
Genzyme Ltd., United Kingdom |
6354.61 |
1270.92 |
7625.53 |
6% |
15 |
6369.61 |
1273.92 |
7643.53 |
18% |
30 |
6399.61 |
1279.92 |
7679.53 |
|
КЦ-599/23.02.2009 |
12.03.2009 |
12.03.2009 |
Неактивен |
3215 |
| Famotidine |
15637/29.12.2006 г. |
FAMOTIDINE ALKALOID, Film coated tablet, 20, mg, Pack: 20 |
Алкалоид ЕООД, България |
Alkaloid-INT d.o.o. Slovenia |
0.82 |
0.16 |
0.98 |
7% |
0.06 |
0.88 |
0.18 |
1.06 |
20% |
0.16 |
1.04 |
0.21 |
1.25 |
промяна на обстоятелства решение КЦPP-2321/20.02.2013; цената е заличена с решение НСР-4837/17.10.2014 (в сила от 16.11.2014 ) |
КЦ-221/19.09.2008 |
21.10.2008 |
21.10.2008 |
Заличен |
113 |
| Famotidine |
16196/06.04.2007 |
Famultran, Film coated tablet, 40, mg, Pack: 30 |
Актавис EАД, България |
Балканфарма- Дупница АД |
2.8 |
0.56 |
3.36 |
7% |
0.2 |
3 |
0.6 |
3.6 |
20% |
0.56 |
3.56 |
0.71 |
4.27 |
|
КЦ-222/19.09.2008 |
21.10.2008 |
21.10.2008 |
Активен |
89 |